Literature DB >> 16981430

Low-density lipoproteins are more electronegatively charged in type 1 than in type 2 diabetes mellitus.

R Gambino1, E Pisu, G Pagano, M Cassader.   

Abstract

Multifactorial etiology is involved in premature atherosclerosis related to diabetes. Most of the mechanisms that are responsible for the etiology in diabetes have remained unsolved so far. Type 1 diabetes is associated with a favorable lipid pattern and with microangiopathy, which is not true for type 2 diabetes, which is related to dyslipidemia and macroangiopathy. The aim of this work was to evaluate the degree of LDL modification related to the types of diabetes. The question is whether the LDL could be differently modified since the pathogenesis of type 1 and type 2 diabetes is different. Thirty-one type 1 (19 male and 12 female) and thirty type 2 (18 male and 12 female) diabetic patients were included in this study. Isolated LDL was analyzed by capillary electrophoresis for diene conjugate content and for electronegativity. LDL from type 1 diabetes subjects showed the highest electrophoretic mobility (P = 0.000). Instead, the diene conjugates contents were higher in the type 2 patients with HbA1c levels > 8% (P = 0.007). In conclusion, the increased diene content in type 2 diabetic subjects in poor glycemic control and the highest LDL mobility found in type 1 subjects show that the LDL undergoes different modifications. In type 2 patients, electronegative LDL are in a state of higher susceptibility to oxidation, whereas in type 1 subjects the finding of electronegative lipoproteins could provide an index of the relative atherogenicity of circulating LDL, especially as LDL has higher electrophoretic mobility than normal subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981430     DOI: 10.1007/s11745-006-5001-1

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  30 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

3.  The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity.

Authors:  J L Sánchez-Quesada; S Benítez; A Pérez; A M Wagner; M Rigla; G Carreras; L Vila; M Camacho; R Arcelus; J Ordóñez-Llanos
Journal:  Diabetologia       Date:  2005-08-18       Impact factor: 10.122

Review 4.  Advanced glycation end products, oxidant stress and vascular lesions.

Authors:  O Chappey; C Dosquet; M P Wautier; J L Wautier
Journal:  Eur J Clin Invest       Date:  1997-02       Impact factor: 4.686

5.  Dual effect of glucose on LDL oxidation: dependence on vitamin E.

Authors:  Paola Otero; Emilio Herrera; Bartolomé Bonet
Journal:  Free Radic Biol Med       Date:  2002-10-15       Impact factor: 7.376

6.  Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.

Authors:  J W Heinecke; H Rosen; A Chait
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

7.  Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus.

Authors:  M Kalousová; J Skrha; T Zima
Journal:  Physiol Res       Date:  2002       Impact factor: 1.881

8.  Capillary electrophoresis to monitor the oxidative modification of low density lipoproteins.

Authors:  J Stocks; N E Miller
Journal:  J Lipid Res       Date:  1998-06       Impact factor: 5.922

9.  The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

Authors:  G Assmann; H Schulte
Journal:  Am Heart J       Date:  1988-12       Impact factor: 4.749

10.  Type 1 and type 2 diabetic patients display different patterns of cellular microparticles.

Authors:  Florence Sabatier; Patrice Darmon; Benedicte Hugel; Valery Combes; Marielle Sanmarco; Jean-Gabriel Velut; Dominique Arnoux; Phillipe Charpiot; Jean-Marie Freyssinet; Charles Oliver; Jose Sampol; Francoise Dignat-George
Journal:  Diabetes       Date:  2002-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.